Operating Income
Operating Income
Neurocrine Biosciences Operating Income decreased by 8.3% to $193.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 719.5%, from $23.60M to $193.40M. Over 3 years (FY 2022 to FY 2025), Operating Income shows an upward trend with a 35.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
Metric ID:
operating_incomeHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.80M | $44.50M | $3.10M | $54.70M | $87.80M | $103.40M | -$114.20M | $73.60M | $141.20M | $150.30M | $99.30M | $145.40M | $183.80M | $142.00M | $23.60M | $145.60M | $239.00M | $210.90M | $193.40M |
| QoQ Change | — | -29.1% | -93.0% | >999% | +60.5% | +17.8% | -210.4% | +164.4% | +91.8% | +6.4% | -33.9% | +46.4% | +26.4% | -22.7% | -83.4% | +516.9% | +64.1% | -11.8% | -8.3% |
| YoY Change | — | — | — | -12.9% | +97.3% | — | <-999% | +34.6% | +60.8% | +45.4% | +187.0% | +97.6% | +30.2% | -5.5% | -76.2% | +0.1% | +30.0% | +48.5% | +719.5% |
Range-$114.20M – $239.00M
CAGR+28.4%
Avg YoY Growth-168.5%
Median YoY Growth+34.6%
Current Streak2 quarters decline
Operating Income at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's operating income?
- Neurocrine Biosciences (NBIX) reported operating income of $193.40M in Q1 2026.
- How has Neurocrine Biosciences's operating income changed year-over-year?
- Neurocrine Biosciences's operating income increased by 719.5% year-over-year, from $23.60M to $193.40M.
- What is the long-term trend for Neurocrine Biosciences's operating income?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's operating income has grown at a 35.5% compound annual growth rate (CAGR), from $249.00M to $619.10M.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.